T1	Participants 27 45	acute hypertension
T2	Participants 140 151	13 patients
T3	Participants 562 585	7 hypertensive episodes
T4	Participants 434 460	diazoxide-treated patients
T5	Participants 884 910	labetalol-treated patients
